Flatiron Health, DeepScribe Unveil Partnership to Provide Oncology-Specific Ambient AI

DeepScribe, which has announced a string of partnerships for its ambient artificial intelligence (AI) technology, today entered into a relationship with Flatiron Health, which uses real-world evidence to provide point-of-care solutions for oncology providers.

According to a statement from Flatiron, the partnership establishes DeepScribe as the first company’s first ambient AI solution partner, setting the stage to integrate DeepScribe’s oncology-specific AI with Flatiron’s proprietary platform, OncoEMR, which reaches 4200 providers in more than 800 community care sites in the United States.

“In recent feedback from oncologists, 91% called DeepScribe easy to use, with adoption rates over 80% within large oncology groups,” Flatiron officials said in their statement.

“We are thrilled to partner with Flatiron and help them continue having a meaningful impact on cancer care,” said Matthew Ko, DeepScribe CEO and cofounder. “We want to ensure that their clinicians can make the most of every encounter, with the information and time they need to truly connect with the patient. The seamless integration with OncoEMR helps make that happen.”

DeepScribe provides clinical documentation for physicians and other medical providers; the “ambient AI” description refers to features that operate in the background, without requiring any proactive steps from the user to provide its solutions. DeepScribe transcribes medical visits in real time and adds key information, saving physicians time and allowing them to concentrate on patients. Of great importance, it integrates with electronic health records, which in the future could allow investigators to extract richer information from medical records for clinical trials and other studies.

According to the statement, DeepScribe's ambient AI is optimized for oncology “by understanding the workflow, terminology, and subtleties of cancer care, automatically creating a structured clinical note.” This includes extracting information from prior visits, gathering contextual information about the length between treatments from the current conversation, and including relevant ICD-10 diagnosis codes in the medical note.

“Technology—including AI tools—are transforming the point of care, improving outcomes for both patients and the clinicians who serve them,” Nina Chavez, vice president of Strategic Partnerships and Alliances, Flatiron Health, said in the statement. “We’re excited to bring DeepScribe’s AI documentation tools to our network of providers, reducing the administrative burden on providers and enabling more meaningful time with patients.”

Each AI-generated note automatically populates the patient chart within OncoEMR for clinician review and signoff, streamlining the workflow even further and giving clinicians more time in their day—and more time for care.

"Oncology care involves complex decision-making and information management," said Dean Dalili, MD, MHCM, DeepScribe chief medical officer. "Our teams have worked closely with oncologists for our AI to capture the nuances and details of a cancer care conversation. Oncologists tell us how well DeepScribe captures terminology, medication names, care plan details. We look forward to each Flatiron clinician benefitting—and in turn, each of their patients benefitting.”